STELARA (Ustekinumab)

(STELARA is registered trademarks JANSSEN)



STELARA is a medicine that contains the active substance Ustekinumab and is available as Single Use Vial.


About Medicine

Generic Name: Ustekinumab
Strength: 45 mg/0.5 and 90 mg/1 mL
Company: JANSSEN
Packing: Single Vial for Injection.

Stelara – Ustekinumab 45 mg/0.5 and 90 mg/1 mL  is supplied for Tenders, Emergency imports, Orphan drug, Reference listed drugs, Comparator Drug, Name patient medicine and Innovator samples etc.


In how many countries STELARA is approved for marketing?

STELARA is available/approved in USA and Europe. We can help you to access it in India.


What is STELARA used for?

STELARA is indicated for the treatment of adult patients with-

1. moderate to severe plaque psoriasis

2. active psoriatic arthritis

3. moderate to severely active Crohn’s disease


How can I get STELARA in India?

STELARA is a prescription only drug and is not approved for marketing in India.

The Indian Pharma (IP) is a consulting pharmaceutical company which assists Patients in accessing medicines in India. The Indian Pharma facilitates such access only against valid prescriptions in conformity with all local laws and regulations.

Patients/ Clinicians / Researchers can contact IP at +91-120-4080562 or write to at –

We facilitate by-

• Helping in documentation to import the medicine for personal use

• Finding Genuine and reliable source in USA, Europe and Japan

• Ensuring 100% transparency.

STELARA can be shipped to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Jaipur, Lucknow, Cochin and Pune and other cities in India.

The Indian Pharma can facilitate the supply of STELARA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement.

The Indian Pharma does not manufacture, supply, re-sell or retail any drugs or medicines. All trademarks and other intellectual property in relation to drugs and medicines supplied to you by suppliers are owned by their respective manufacturers or licensees


Can I get STELARA even if I am not based in India?

Almost all countries across the world have provisions for granting access to drugs prior to marketing approval for personal use for patients who have exhausted all other treatment options available in their country
The Indian Pharma (IP) can help patients in accessing/importing STELARA, unapproved in their home country against a legitimate prescription and in conformity with all local laws and regulations of their home country.

Send your enquiry to find-

STELARA in South East Asia – China (Beijing, Chongqing, Shanghai, Tianjin and Shenzhen), Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong.

STELARA in United Arab Emirates – Iraq, Iran, Saudi Arabia, Jordan.

STELARA in North America – Mexico.

STELARA in South America – Argentina, Brazil, Chile, Colombia, Peru, Venezuela.

STELARA in Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia.

STELARA in Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia.

STELARA in African Countries – Algeria, Mauritius, Uganda, Zimbabwe.

STELARA in Australia and New Zealand.


How is STELARA used?

STELARA should be administered under the guidance of specialist doctor having experience in managing immunological disorders.

Recommended dosage:

Crohn’s Disease Recommended Initial Adult Intravenous Dosage
A single intravenous infusion using weight-based dosing:


Wt. Range (kilogram) Recommended Dosage
Up to 55k 260mg (2 vials)
Greater than 55kg to 85 kg 390mg (3 vials)
Greater than 85 kg 520mg (4 vials)


Crohn’s Disease Recommended Maintenance Adult Subcutaneous Dosage: A subcutaneous 90 mg dose 8 weeks after the initial intravenous dose, then every 8 weeks thereafter.
If the patient develops certain serious side effects then doctor may interrupt or stop treatment, or reduce the dose. See the summary of product characteristics on company official website for more information.


Are there any side-effects/ adverse reactions/precautions associated with treatment with STELARA?

It is recommended to seek your doctor’s medical advice about side effects


How do I contact The Indian Pharma?

You can use different channel to contact The Indian Pharma (IP)
Tele & Mobile: You can reach us on +91 8826990915 or +91-120-4080562 on any working days.
Email: We can also address your enquiries if sent directly to We will respond within 24 hours after receiving your mail. Please mention detailed enquiry, your contact number with ISD code while sending your mail. We will respond within 1 working days after receiving your query form.


What information do you need to help patient in assisting documentation for STELARA import for personal use?

We will require the following documents to help in documentation for Named-Patient import

  • Doctor’s Prescription – We would require prescription from Registered Medical Practitioner Stating Product name, dosage, duration of treatment and diagnosis
  • Patient’s Medical history – We would require all test reports and Medical reports of the patient for last 3 months.
  • Patient’s Identity card – We will require scan copy of Patient’s identity card and proof of residence to initiate documentation process. You can use copy of Passport, Driving License, Employee ID card or any Photo ID document as your Identity card.

Contact Details

The Indian Pharma
905, I - Thum Business Park,
Plot No. A-40, Unit No. 5, Tower A,
Sector-62, Noida – 201301 (India)

Phone No.- +91-120-4080562.
M: +91 9650877511

WhatsApp: +91 9650877511
QQID:- 1927411523
Skype ID: tuhinsharma